.svg){kind=small}
Where to Buy
YEM is stocked at 22 licensed dispensaries across New York, with the deepest coverage in New York, Syracuse, Albany, Bayside, and Bushwick. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, YEM concentrated 89.31% of sales in Edible, down 12.26% year over year and down 70.49% month over month, while Tincture & Sublingual expanded to 10.69% share with a 194.58% month-over-month surge and no year-over-year baseline. The brand’s total sales declined 1.76% year over year as average price rose 19.05% to $23.66, indicating mix and pricing moved in opposite directions. Edible average price sat at $22.03 versus $61.65 in Tincture & Sublingual, and the swing from a 70.49% monthly drop in Edible alongside a 194.58% monthly rise in Tincture & Sublingual implies a short-term reallocation toward higher-ticket formats even as the core category contracted.
The shift toward Tincture & Sublingual at 10.69% share, paired with a 19.05% brand-wide price increase and a 70.49% monthly pullback in Edible, implies YEM is leaning into premium-priced, lower-volume formats to offset softness in its core. With Edible down 12.26% year over year but Tincture & Sublingual surging month over month, the pattern suggests a positioning pivot toward margin protection over volume recovery, especially in New York where Edible ranking data is unavailable and price-led differentiation may be more defensible than share-led expansion.
Competitive Landscape
YEM sits at rank #82 in July 2026, improving 4 positions from #86 year over year, but sliding 32 spots from #50 three months ago and sitting below its peak of #49 from March 2026; meanwhile, Camino climbed from #2 to #1 while growing sales 15.9% YoY, and Off Hours fell from #1 to #2 with a 10.5% YoY sales decline, indicating that YEM’s slight YoY rank gain amid a recent quarter’s drop positions it as a volatile mid-tail player that must stabilize month-to-month momentum to convert its annual improvement into sustained share.
Notable Products
Strawberry Lemonade Sugar Free Rosin Gummies 10-Pack (100mg) posted the steepest decline in July 2026 at -80.4% MoM as it fell to rank 4, while Sleep - CBN/THC 1:1 Elderberry Live Rosin Gummies 10-Pack (100mg CBN, 100mg THC) also slid -53.9% MoM yet still held rank 1 with $2,293. Black Cherry Sugar Free Rosin Gummies 10-Pack (100mg) delivered the largest MoM gain at +104.3% to rank 2, contrasting with Mango Live Rosin Gummies 10-Pack (500mg) at -93.7% MoM down to rank 7. With eight of the top ten SKUs in Edibles and a sugar-free variant surging while legacy flavors contracted, the mix implies YEM is pivoting toward functional and dietary Edibles where momentum is concentrating near the top ranks.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
